• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Evotec AG

News headline image
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
May 19, 2022
From Evotec AG
Via AccessWire
Tickers EVO EVOTF
News headline image
Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes
May 17, 2022
From Evotec AG
Via AccessWire
News headline image
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership
May 10, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
May 10, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022
May 04, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures
April 12, 2022
From Evotec AG
Via AccessWire
Tickers EVO EVOTF
News headline image
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
April 08, 2022
From Evotec AG
Via AccessWire
Tickers EVO EVOTF
News headline image
Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022
April 05, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme
March 21, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day
March 02, 2022
From Evotec AG
Via AccessWire
Topics Artificial Intelligence
Tickers EVO
News headline image
Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol
March 01, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
February 04, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology
January 25, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases
January 18, 2022
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
January 11, 2022
From Evotec AG
Via AccessWire
News headline image
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
January 03, 2022
From Evotec AG
Via AccessWire
Tickers EVO EVOTF
News headline image
Evotec Receives US$ 18 M Grant for Women's Health
December 16, 2021
From Evotec AG
Via AccessWire
News headline image
Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership
November 18, 2021
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Update
November 11, 2021
From Evotec AG
Via AccessWire
Topics Initial Public Offering
News headline image
Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb
November 10, 2021
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec SE Announces Closing of Public Offering
November 09, 2021
From Evotec AG
Via AccessWire
Tickers EVO
News headline image
Evotec SE Announces Placement of Its Public Offering of American Depositary Shares
November 03, 2021
From Evotec AG
Via AccessWire
Topics Regulatory Compliance
News headline image
Evotec SE To Announce Results for the First Nine Months 2021 On 11 November 2021
November 03, 2021
From Evotec AG
Via AccessWire
Topics Regulatory Compliance
News headline image
Evotec SE: Announces Launch of Public Offering of American Depositary Shares
October 26, 2021
From Evotec AG
Via AccessWire
Topics Regulatory Compliance
News headline image
Evotec Provides Preliminary Nine Month Financial Results
October 26, 2021
From Evotec AG
Via AccessWire
News headline image
Evotec SE files Registration Statement for Proposed Offering of American Depositary Shares
October 11, 2021
From Evotec AG
Via AccessWire
Topics Regulatory Compliance
News headline image
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Cell Type
October 08, 2021
From Evotec AG
Via AccessWire
News headline image
Evotec Announces Bristol Myers Squibb Opt-in of EVT8683 as the First Programme from iPSC-based Neurodegeneration Collaboration
September 02, 2021
From Evotec AG
Via AccessWire
News headline image
Just - Evotec Biologics Opens J.POD 1 US in Redmond, Washington
August 11, 2021
From Evotec AG
Via AccessWire
News headline image
Evotec SE Reports First Half-Year 2021 Results and Corporate Updates
August 11, 2021
From Evotec AG
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap